CollPlant Biotechnologies Ltd.

CLGNNASDAQHealthcare● Active

$0.37

$-0.00(-0.27%)

Market Cap$4522010

P/E Ratio—

52W High$3.232

52W Low$0.271

Avg Volume81K

Open$0.38

Beta0.64

Overview

Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

CollPlant Biotechnologies Ltd. (CLGN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CLGN · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.03Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)389000.00Full revenue history

Dividend YieldNo DividendDividend history

Shares Outstanding12.2MShares outstanding history

Next EarningsAug 20, 2026Est.Earnings history

Explore CollPlant Biotechnologies Ltd. Data

Market Cap$4.5M

Analyst Forecast$13 · Buy

DividendsNo Dividend

Revenue$2.4M+360.39%

EarningsEPS $-0.94+35.17%

PE Ratio—

Financial Snapshot

Full Financials

FY 2025Revenue$2.4M▲ +360.39% YoY

202320242025

FY 2025Net Income-$11.5M▲ +30.83% YoY

202320242025

FY 2025EPS$-0.94▲ +35.17% YoY

202320242025

TTM:Revenue: $389000.00Net Income: -$13.1MEPS: $-1.03View income statement →

Analyst Ratings & Price Target

Full Forecast

Buy5 analysts

Strong Buy

Buy

Hold

Sell

Strong Sell

12-Month Price Target

$11.00Low

$0.37Current

$12.50Avg Target3278.38% upside

$14.00High

Total: 5 · Buy rate: 80.0%

The CLGN analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $12.50, representing +3278.38% upside from the current price of $0.37.

Competitors & Peers

#TickerCompanyPriceChangeMkt Cap

CLGN

CollPlant Biotechnologies Ltd.

$0.37-0.27%$4.5M #2

CVKD

Cadrenal Therapeutics, Inc. Common Stock

$4.21-5.18%$12.1M #3

ENLV

Enlivex Therapeutics Ltd.

$0.71+0.59%$17.4M #4

KLTO

Klotho Neurosciences, Inc.

NeuroSense Therapeutics Ltd.

$0.75+0.20%$18.5M

Stock Performance

Full History

1D-0.27%

1W-9.54%

1M-8.01%

3M-38.94%

YTD-73.57%

1Y-78.61%

5Y-97.83%

About CollPlant Biotechnologies Ltd.

CEOYehiel Tal

IPO DateJan 31, 2018

Employees57

CountryIL

Websitecollplant.com

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) b…

Biotechnology HealthcareNASDAQADRIL

About Stock Overview & Key Data

CollPlant Biotechnologies Ltd. (CLGN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 31, 2018. As of the latest trading session, CLGN stock price is $0.37, with a market capitalization of $4.5M. The stock has returned -78.61% over the past 12 months and -73.57% year-to-date.

According to 5 Wall Street analysts, the consensus rating for CollPlant Biotechnologies Ltd. stock is Buy, with an average 12-month price target of $12.50. In fiscal year 2025, CollPlant Biotechnologies Ltd. reported revenue of $2.4M and net income of -$11.5M. For detailed data — including CollPlant Biotechnologies Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, CollPlant Biotechnologies Ltd. (CLGN) stock price is $0.37. The stock is traded on NASDAQ under the ticker symbol CLGN. The 52-week range is $0.27 – $3.23.

CLGN stock priceCLGN quote todaylive ticker

Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice